Dementia & Alzheimers
This session addresses the changing landscape of neurodegenerative cognitive decline, focusing heavily on Alzheimer’s disease and vascular dementia. Topics include early biomarker identification, amyloid-beta targeted therapies, and novel neuropsychological screening tools. Renowned researchers at Stroke 2027 will discuss structural changes, genetic predispositions, and comprehensive memory care models. Participants will explore multi-disciplinary strategies designed to manage behavioral symptoms and slow disease progression, translating laboratory insights into proactive patient management.